Filing Details
- Accession Number:
- 0001209191-18-046244
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-08-10 16:48:07
- Reporting Period:
- 2018-08-09
- Accepted Time:
- 2018-08-10 16:48:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 921299 | Fibrogen Inc | FGEN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1621330 | Jorma Routti | C/O Fibrogen, Inc. 409 Illinois St. San Francisco CA 94158 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-08-09 | 6,000 | $18.00 | 137,540 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-08-09 | 3,700 | $59.60 | 133,840 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-08-09 | 2,028 | $60.36 | 131,812 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-08-09 | 272 | $61.21 | 131,540 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2018-08-09 | 6,000 | $0.00 | 6,000 | $18.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2024-11-13 | No | 4 | M | Direct |
Footnotes
- Shares sold pursuant to a 10b5-1 plan.
- The shares were sold at prices ranging from $59.10 to $60.05. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares were sold at prices ranging from $60.10 to $60.90. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares were sold at prices ranging from $61.10 to $61.40. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Fully vested.
Billionaire Hedge Funds
